The survival benefit of a cardiac resynchronization therapy-defibrillator (CRT-D) lasts for several years in patients with mild-to-moderate symptoms of heart failure (HF), a reduced ejection fraction, ...
Primary analysis of the MADIT-CRT trial demonstrated that male and female patients with NYHA functional class I or II, left ventricular ejection fraction (LVEF) ≤0.30, and QRS duration ≥130 ms are ...
AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...
San Francisco, CA - When a heart-failure patient has a defibrillator-equipped cardiac resynchronization therapy (CRT-D) device, antitachycardia pacing (ATP) is preferable to a shock for the treatment ...
Among patients with nonischemic cardiomyopathy who require cardiac resynchronization therapy, a pacemaker may have comparable efficacy and more cost efficiency compared with a defibrillator, according ...
Cardiac resynchronization therapy with defibrillator (CRT-D) can help certain patients with non-left bundle branch block (non-LBBB) with heart failure if traditional, implantable cardioverter ...
September 17, 2010 (Natick, Massachusetts) — The FDA is expanding the approved indications for three Boston Scientific cardiac resynchronization defibrillators (CRT-D) to include patients with milder ...
MILAN, Italy--(BUSINESS WIRE)--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today that the INTENSIA ...
Medical device maker Medtronic plc MDT recently announced the receipt of FDA approval for its Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for the treatment ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...
Please provide your email address to receive an email when new articles are posted on . Cardiac resynchronization therapy defibrillator implantation conferred improved outcomes vs. implantable ...
AMSTERDAM -- A cardiac resynchronization therapy (CRT) upgrade produced solid clinical benefit for patients with pacing-induced heart failure with reduced ejection fraction (HFrEF), the small BUDAPEST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback